Fractyl Health Stock Plummets 50% Amid Class Action Lawsuit Concerns

Key Facts

1Fractyl Health (GUTS) stock price dropped by 50% during Friday's trading session.

2The sharp decline occurred despite the company reporting positive results from its REMAIN-1 clinical trial.

3Investor concerns regarding potential class action lawsuits are weighing heavily on the stock's performance.

Fractyl Health (GUTS) stock price dropped by 50% during Friday's trading session on October 16, 2026. Benzinga reported that the sharp decline occurred despite the company announcing positive results from its REMAIN-1 clinical trial, as legal concerns took precedence over clinical progress.

Investor concerns regarding potential class action lawsuits are weighing heavily on the stock's performance and future outlook. Prior to this volatility, GUTS closed at $4.16 on October 15, 2026, before the emergence of legal risks triggered the massive sell-off.